海旭医疗品牌怎么样 申请店铺

我要投票 海旭医疗在医疗用品行业中的票数:412 更新时间:2025-08-11
海旭医疗是哪个国家的品牌?「海旭医疗」是 日照海旭医疗器械有限公司 旗下著名品牌。该品牌发源于山东省日照市,由创始人王 *在2006年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海旭医疗品牌出海!将品牌入驻外推网,定制海旭医疗品牌推广信息,可以显著提高海旭医疗产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

海旭医疗怎么样

日照海旭医疗器械有限公司,成立于2006年,位于美丽的海滨城市--日照,是一家专业生产械准字号的膏药生产厂家。目前以专业研发、生产和销售械准字号膏药为主要业务,是专业的膏药生产基地。

海旭医疗以市场为导向,高新技术为内涵,积极开发符合市场需求的产品。公司自创建以来先后投入资金,兴建起符合医疗器械生产质量管理规范的生产车间、质量检验控制室、仓库等设施,引进具有国际先进水平的生产设备,为生产“疗效好、见效快”的海旭牌系列产品提供了硬件保障;同时海旭医疗十分注重生产经营管理及专业技术人才的引进与培养,着力打造强有力的管理团队,为创建海旭品牌提供了软件保障。

海旭医疗主要生产暖宫贴、远红外理疗贴、磁疗贴、穴位敷贴、灸热贴、退热贴、烫熨治疗包、中医穴位透皮贴等医院临床和终端诊所系列产品。公司的经营范围有:骨科,妇科和小儿科等。经营品种高达数百种,经营方式有:代理和贴牌代加工。

针对目前市场上同类产品较多,竞争也比较激烈的情况,公司始终坚持务实、开拓、创新、发展的经营理念,不断创新贴膏生产工艺,同时注重绿色、环保、节能,致力打造“海旭”品牌,积极开拓市场发展空间,促使公司形成运作规范化、管理科学化、监控制度化、效益较大化的管理轨道。

海旭医疗秉承“科技的光芒源于人性设计,海旭的品牌源于产品品质”的经营理念。凭借过硬的产品质量,完整的产品结构,优秀的营销团队,宽阔的营销思路,灵活的营销体制,完善的售后服务,线上线下的推广力度,正逐步建立起覆盖全国的营销网络。


Rizhao Haixu Medical Equipment Co., Ltd., founded in 2006, is located in Rizhao, a beautiful coastal city. It is a plaster manufacturer specializing in the production of xizhun brand. At present, our main business is professional R & D, production and sales of xizhun plaster, which is a professional plaster production base. Haixu medical is market-oriented, high-tech oriented, and actively develops products that meet the market demand. Since its establishment, the company has invested in the construction of production workshops, quality inspection control rooms, warehouses and other facilities in line with the production quality management standards of medical devices, introduced internationally advanced production equipment, and provided hardware guarantee for the production of Haixu brand series products with "good effect and quick effect"; at the same time, Haixu medical attaches great importance to production management and professional technology The introduction and training of talents, and efforts to create a strong management team, provide software guarantee for the creation of Haixu brand. Haixu medical mainly produces warm palace paste, far-infrared physical therapy paste, magnetic therapy paste, acupoint application, moxibustion hot paste, antipyretic paste, ironing treatment package, traditional Chinese medicine acupoint transdermal paste and other hospital clinical and terminal clinic products. The business scope of the company includes: Orthopedics, gynecology and pediatrics, etc. There are hundreds of business varieties, including agency and OEM. In view of the current situation that there are many similar products and fierce competition in the market, the company always adheres to the business philosophy of pragmatism, exploration, innovation and development, constantly innovates the paste production process, pays attention to green, environmental protection and energy conservation, strives to build the brand of "Haixu", actively opens up the market development space, and promotes the company to form a standardized operation, scientific management and monitoring system A management track with high efficiency. Haixu medical adheres to the business philosophy that "the light of science and technology comes from human design, and the brand of Haixu comes from product quality". With excellent product quality, complete product structure, excellent marketing team, broad marketing ideas, flexible marketing system, perfect after-sales service, online and offline promotion, a nationwide marketing network is gradually established.

本文链接: https://brand.waitui.com/08710bf8c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

开源证券刘呈祥:推动本轮银行股行情的核心因素有三点

开源证券银行业首席分析师刘呈祥认为,推动本轮银行股行情的核心因素主要有三点:第一点也是最主要的逻辑,就是在低利率阶段,偏好稳定收益的投资者,会促使稳定红利资产进行价值重估;第二点是在本轮行情以前,银行板块处于长期被低估的状态,本轮行情其实也有修复逻辑;第三点是市场风格变化和以险资为代表的资金驱动,过去几年配置银行板块的公募基金占比并不高,随着政策引导中长期资金入市,以及中长期投资考核维度的优化,以险资为代表的中长期资金更愿意配置银行股。(证券时报)

2小时前

机构今日买入恒宝股份等21股,抛售宁波韵升3.07亿元

盘后数据显示,8月11日龙虎榜中,共37只个股出现了机构的身影,21只股票呈现机构净买入,16只股票呈现机构净卖出。当天机构净买入前三的股票分别是恒宝股份、超捷股份、创新医疗,净买入金额分别是1.20亿元、1.11亿元、7040万元。当天机构净卖出前三的股票分别是宁波韵升、中欣氟材、东芯股份,净流出金额分别是3.07亿元、1.55亿元、9062万元。(第一财经)

2小时前

中国国新等在杭州新设企业管理公司,注册资本1000万元

36氪获悉,爱企查App显示,近日,国新创新(杭州)企业管理有限公司成立,法定代表人为黄杰,注册资本1000万元人民币,经营范围为企业管理、企业管理咨询。股权穿透图显示,该公司由中国国新控股有限责任公司旗下国新国同(杭州)股权投资有限公司、杭州市人民政府国有资产监督管理委员会旗下杭州产业投资有限公司等共同持股。

2小时前

万华化学:上半年净利润61.23亿元,同比下降25.1%

36氪获悉,万华化学披露2025年半年报,上半年实现营业收入909.01亿元,同比下降6.35%;归属于上市公司股东的净利润61.23亿元,同比下降25.1%;基本每股收益1.95元。

2小时前

小米集团获南向资金净买入5.62亿港元

南向资金今日小幅净买入3834万港元。其中小米集团、康方生物、东方甄选净买入额位列前三,分别获净买入5.62亿港元、3.06亿港元、1.88亿港元。净卖出前三个股为小鹏汽车、信达生物、腾讯控股,分别遭净卖出6.65亿港元、5.28亿港元、3.4亿港元。(第一财经)

2小时前

本页详细列出关于海旭医疗的品牌信息,含品牌所属公司介绍,海旭医疗所处行业的品牌地位及优势。
咨询